Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 3
1970 2
1971 3
1972 1
1973 4
1974 3
1975 3
1976 6
1977 6
1978 6
1979 4
1980 5
1981 3
1982 5
1983 5
1984 3
1985 5
1986 5
1987 3
1988 5
1989 6
1990 3
1991 1
1992 4
1993 7
1994 4
1995 4
1996 2
1997 1
1999 2
2000 4
2001 7
2002 9
2003 9
2004 6
2005 3
2006 4
2007 3
2008 1
2009 2
2010 3
2011 1
2012 4
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

168 results
Results by year
Filters applied: . Clear all
Page 1
The 5-HT4 receptor: a place in the sun.
Bockaert J, Fozard JR, Dumuis A, Clarke DE. Bockaert J, et al. Among authors: Fozard JR. Trends Pharmacol Sci. 1992 Apr;13(4):141-5. doi: 10.1016/0165-6147(92)90051-7. Trends Pharmacol Sci. 1992. PMID: 1589907 Review. No abstract available.
Basic mechanisms of antimigraine drugs.
Fozard JR. Fozard JR. Adv Neurol. 1982;33:295-307. Adv Neurol. 1982. PMID: 7034488 Review. No abstract available.
The 5-HT4 receptor: naughty, but nice.
Clarke DE, Craig DA, Fozard JR. Clarke DE, et al. Among authors: Fozard JR. Trends Pharmacol Sci. 1989 Oct;10(10):385-6. doi: 10.1016/0165-6147(89)90177-6. Trends Pharmacol Sci. 1989. PMID: 2694534 Review. No abstract available.
Suxamethonium pains and electromyograph recordings in children.
Fozard JR, Manford ML, Harris R. Fozard JR, et al. Br J Anaesth. 1977 Oct;49(10):1057-9. doi: 10.1093/bja/49.10.1057. Br J Anaesth. 1977. PMID: 921869 Free article. Clinical Trial.
5-HT1C receptor activation: a key step in the initiation of migraine?
Fozard JR, Gray JA. Fozard JR, et al. Trends Pharmacol Sci. 1989 Aug;10(8):307-9. doi: 10.1016/0165-6147(89)90061-8. Trends Pharmacol Sci. 1989. PMID: 2686127 Review. No abstract available.
168 results
Jump to page
Feedback